US DEPARTMENT OF JUSTICE: ASSERTIO THERAPEUTICS INC. AGREES TO PAY $3.6M TO RESOLVE ALLEGATIONS THAT IT VIOLATED FALSE CLAIMS ACT IN CONNECTION WITH MARKETING ITS FENTANYL PRODUCT

Reuters · 05/09/2025 15:59

Please log in to view news